Isabel Leroux‐Roels

6.2k total citations · 1 hit paper
74 papers, 2.7k citations indexed

About

Isabel Leroux‐Roels is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Isabel Leroux‐Roels has authored 74 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Epidemiology, 29 papers in Infectious Diseases and 14 papers in Immunology. Recurrent topics in Isabel Leroux‐Roels's work include Influenza Virus Research Studies (24 papers), Respiratory viral infections research (24 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Isabel Leroux‐Roels is often cited by papers focused on Influenza Virus Research Studies (24 papers), Respiratory viral infections research (24 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). Isabel Leroux‐Roels collaborates with scholars based in Belgium, United States and Germany. Isabel Leroux‐Roels's co-authors include Geert Leroux‐Roels, Frédéric Clément, Mamadou Dramé, Jeanne‐Marie Devaster, Thomas Vanwolleghem, Astrid Borkowski, Emmanuel Hanon, Philippe Moris, Jerina Boelens and Edouard Ledent and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Isabel Leroux‐Roels

68 papers receiving 2.6k citations

Hit Papers

Respiratory Syncytial Virus Prefusion F Protein Vaccine i... 2023 2026 2024 2025 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
    2023 405 citations Alberto Papi, Michael G. Ison et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Leroux‐Roels Belgium 24 1.8k 999 763 438 183 74 2.7k
Todd F. Hatchette Canada 31 1.2k 0.7× 1.3k 1.3× 238 0.3× 335 0.8× 145 0.8× 139 2.7k
Kazunori Oishi Japan 30 1.5k 0.9× 800 0.8× 382 0.5× 231 0.5× 48 0.3× 172 3.3k
Florence Morfin France 30 1.8k 1.0× 969 1.0× 314 0.4× 362 0.8× 33 0.2× 83 2.8k
Katsumi Mizuta Japan 34 2.1k 1.2× 1.8k 1.8× 352 0.5× 536 1.2× 376 2.1× 159 3.5k
Aubree Gordon United States 37 1.3k 0.7× 3.2k 3.2× 373 0.5× 502 1.1× 96 0.5× 110 4.8k
Alireza Eshaghi Canada 26 1.5k 0.9× 793 0.8× 121 0.2× 313 0.7× 168 0.9× 62 2.1k
Nguyen Tran Chinh Vietnam 23 1.5k 0.8× 1.5k 1.5× 772 1.0× 351 0.8× 249 1.4× 34 3.4k
Samson S. Y. Wong Hong Kong 27 1.1k 0.6× 1.9k 1.9× 244 0.3× 382 0.9× 150 0.8× 56 3.2k
Christian Herzog Switzerland 28 1.0k 0.6× 884 0.9× 505 0.7× 296 0.7× 22 0.1× 111 2.4k
Steven J. Drews Canada 34 2.5k 1.4× 1.7k 1.7× 209 0.3× 469 1.1× 196 1.1× 186 3.9k

Countries citing papers authored by Isabel Leroux‐Roels

Since Specialization
Citations

This map shows the geographic impact of Isabel Leroux‐Roels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Leroux‐Roels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Leroux‐Roels more than expected).

Fields of papers citing papers by Isabel Leroux‐Roels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Leroux‐Roels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Leroux‐Roels. The network helps show where Isabel Leroux‐Roels may publish in the future.

Co-authorship network of co-authors of Isabel Leroux‐Roels

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Leroux‐Roels. A scholar is included among the top collaborators of Isabel Leroux‐Roels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Leroux‐Roels. Isabel Leroux‐Roels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Onofrio, Valentino, Matthias Verstraete, Fien De Boever, et al.. (2025). A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults. Vaccines. 13(9). 922–922.
2.
D’Onofrio, Valentino, Alfredo Santana, Fien De Boever, et al.. (2025). AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells. Frontiers in Immunology. 16. 1623405–1623405.
3.
Aerssens, Annelies, et al.. (2024). Microbiological evaluation of ultraviolet C light-emitting diodes for disinfection of medical instruments. Heliyon. 10(17). e37281–e37281. 4 indexed citations
4.
5.
Leroux‐Roels, Isabel, Jacques Bruhwyler, Nicola Groth, et al.. (2024). Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults. Vaccines. 12(12). 1391–1391. 2 indexed citations
6.
Leroux‐Roels, Isabel, et al.. (2024). Safety and Immunogenicity of an Adjuvanted Clostridioides difficile Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study. The Journal of Infectious Diseases. 231(3). e511–e520. 3 indexed citations
7.
Waele, Jan J. De, Isabel Leroux‐Roels, & Andrew Conway Morris. (2024). Environmental sustainability and antimicrobials: an underestimated problem with far-reaching consequences. Intensive Care Medicine. 50(3). 453–456. 3 indexed citations
8.
Leroux‐Roels, Isabel, et al.. (2023). Human Immunity and Susceptibility to Influenza A(H3) Viruses of Avian, Equine, and Swine Origin. Emerging infectious diseases. 29(1). 98–109. 3 indexed citations
9.
Ison, Michael G., Alberto Papi, Joanne M. Langley, et al.. (2023). A Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3-OA) is Efficacious in Adults ≥ 60 Years of Age (YOA). Diabetologie und Stoffwechsel. 18(S 01). S54–S54. 2 indexed citations
10.
Ison, Michael G., Alberto Papi, Joanne M. Langley, et al.. (2023). 1936. Efficacy of One Dose of the Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Adults ≥ 60 Years of Age Persists for 2 RSV Seasons. Open Forum Infectious Diseases. 10(Supplement_2). 4 indexed citations
11.
Matheeussen, Veerle, Annette Schuermans, Hilde Jansens, et al.. (2023). Epidemiology and molecular typing of multidrug-resistant bacteria in tertiary hospitals and nursing homes in Flanders, Belgium. European Journal of Clinical Microbiology & Infectious Diseases. 43(1). 187–194.
12.
Arkel, Andreas van, et al.. (2021). Feedback of ATP measurement as a tool for reducing environmental contamination in hospitals in the Dutch/Belgian border area. International Journal for Quality in Health Care. 33(4).
13.
Leroux‐Roels, Isabel, et al.. (2021). In vitro comparison of 3 different brushes for manual cleaning of endoscopes. Infection Control and Hospital Epidemiology. 43(8). 1076–1078. 1 indexed citations
14.
Coster, Ilse De, Isabel Leroux‐Roels, Ananda S Bandyopadhyay, et al.. (2020). Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. The Lancet. 397(10268). 39–50. 58 indexed citations
15.
Vandendriessche, Stien, Jerina Boelens, Liselotte Coorevits, et al.. (2020). Toilet drain water as a potential source of hospital room-to-room transmission of carbapenemase-producing Klebsiella pneumoniae. Journal of Hospital Infection. 106(2). 232–239. 14 indexed citations
16.
Dodémont, Magali, M. Ángeles Argudín, Julie Willekens, et al.. (2018). Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: Result of a Belgian national survey. Journal of Cystic Fibrosis. 18(1). 86–93. 19 indexed citations
17.
Rimmelzwaan, Guus F., Isabel Leroux‐Roels, Sarah C. Gilbert, & Angus Thomson. (2015). Influenza vaccines: Where do we stand? Where do we go?. Vaccine. 33(49). 7026–7028. 2 indexed citations
18.
Leroux‐Roels, Geert, Isabel Leroux‐Roels, Frédéric Clément, et al.. (2014). Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines. Human Vaccines & Immunotherapeutics. 10(8). 2211–2219. 45 indexed citations
19.
Leroux‐Roels, Isabel, Geert Leroux‐Roels, Frédéric Clément, et al.. (2012). A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults. The Journal of Infectious Diseases. 206(8). 1280–1290. 112 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Todd F. Hatchette Breakdown of academic impact, for papers by Kazunori Oishi Breakdown of academic impact, for papers by Florence Morfin Breakdown of academic impact, for papers by Katsumi Mizuta Breakdown of academic impact, for papers by Aubree Gordon Breakdown of academic impact, for papers by Alireza Eshaghi Breakdown of academic impact, for papers by Nguyen Tran Chinh Breakdown of academic impact, for papers by Samson S. Y. Wong Breakdown of academic impact, for papers by Christian Herzog Breakdown of academic impact, for papers by Steven J. Drews
Rankless by CCL
2026